Travel & financial grants

MMRF

Michigan Society of Hematology and Oncology

The provided page, hosted by the Michigan Society of Hematology and Oncology (MSHO), serves as a directory of various pharmaceutical patient assistance programs. These programs are primarily offered by individual pharmaceutical companies to help patients with the cost, access, and reimbursement of specific medications. The content does not mention or describe any grants specifically for patient travel assistance, such as coverage for flights, hotel stays, or gas expenses.

HealthWell Foundation

This grant from the HealthWell Foundation provides financial assistance for prescription drug copays or Medicare Part B insurance premiums for patients being treated for Multiple Myeloma. To qualify, applicants must have Medicare (Part B for premium assistance), be receiving treatment in the United States, and have a household income up to 500% of the Federal Poverty Level, adjusted for household size and cost of living areas.

HealthWell Foundation

This grant from the HealthWell Foundation provides financial assistance for prescription drug copays or Medicare Part B insurance premiums for patients diagnosed with Multiple Myeloma. To qualify, applicants must have Medicare, be receiving treatment in the United States, and have a household income up to 500% of the Federal Poverty Level, adjusted for household size and cost of living. The maximum award level for this fund is $8,000.

Multiple Myeloma Research Foundation (MMRF)

The Multiple Myeloma Research Foundation (MMRF) provides a resource hub listing various external programs that offer financial and transportation support for multiple myeloma patients. While MMRF does not directly provide financial assistance, the listed programs can help with treatment-related transportation costs, including rides, gas cards, and long-distance ground transportation, as well as medication co-pays and other non-medical expenses.

Multiple Myeloma Research Foundation (MMRF)

The Multiple Myeloma Research Foundation (MMRF) provides an online resource, "Multiple Myeloma Financial Assistance & Support Programs," which lists various external organizations offering financial and transportation support. While MMRF does not directly provide grants under this program, it guides patients to resources that can assist with medication costs, transportation to treatment, and other non-medical expenses. Eligibility and application processes are determined by the individual third-party providers.

The Multiple Myeloma Research Foundation (MMRF)

The Multiple Myeloma Research Foundation (MMRF) offers this 'Financial Assistance & Support Programs' page as a comprehensive resource, listing various external organizations that provide financial aid. While the page helps patients find assistance for medication co-pays, treatment transportation, and other non-medical expenses, the MMRF itself does not directly provide grants or financial support. Patients are directed to contact the listed third-party organizations for specific eligibility and application details.

PAN Foundation

This PAN Foundation grant provides financial assistance for medication copays for patients diagnosed with multiple myeloma. While primarily focused on medication, the PAN Foundation generally offers transportation assistance, which may be available to eligible patients. Applicants typically need to verify their income.

PAN Foundation

The PAN Foundation offers a Multiple Myeloma Medication Copay Grant to assist eligible patients with the costs of medication copays and transportation purchases. To qualify, applicants must verify their income and insurance premiums, though specific income eligibility requirements are not detailed.

PAN Foundation

The PAN Foundation offers a Multiple Myeloma medication copay grant. Although this page focuses on medication, the foundation's general information indicates that transportation purchases may be covered under their grants. Applicants must verify their income for eligibility.

PAN Foundation

This grant, offered by the PAN Foundation, provides financial assistance for multiple myeloma patients primarily covering medication copay costs. Funds from a PAN grant may also be used to cover transportation purchases. Eligibility requires applicants to verify their income.

PAN Foundation

This grant, offered by the PAN Foundation, primarily assists with Multiple sclerosis medication copays. While not explicitly stated for this specific grant, the PAN Foundation generally offers transportation assistance, meaning grant funds may cover transportation purchases for eligible patients. Eligibility involves verifying income and insurance status.

PAN Foundation

The PAN Foundation offers assistance for patients with Multiple Sclerosis, primarily for medication copays. While the foundation provides various types of grants, including general transportation grants, the specific travel benefits for this Multiple Sclerosis grant are not detailed in the provided content. Applicants must verify their income to determine eligibility.

Agios

The myAgios Patient Support Program provides educational materials and financial support information related to the drug PYRUKYND for individuals with pyruvate kinase (PK) deficiency. Patients receive personalized support from dedicated Patient Support Managers. This program does not explicitly mention travel assistance.

PAN Foundation

This grant, named "Myasthenia gravis financial assistance for insurance premiums," provides financial assistance to eligible patients with Myasthenia Gravis for their insurance premiums. While the PAN Foundation offers general transportation grants, the provided information does not indicate that this specific fund covers travel expenses. Eligibility likely requires income verification.

PAN Foundation

This is an open grant from the PAN Foundation, offering financial assistance for insurance premiums for patients with Myasthenia gravis. While the foundation generally offers transportation assistance programs, this specific grant page does not detail explicit travel coverage for this fund.

The Assistance Fund

The Myasthenia Gravis Financial Assistance Program, offered by The Assistance Fund (TAF), provides financial assistance for out-of-pocket costs including prescription drugs, health insurance premiums, therapy administration, and travel expenses (ground, air, meals, hotel) to treatment centers or specialist visits. Eligible patients are U.S. citizens or permanent residents diagnosed with Myasthenia Gravis, prescribed an FDA-approved treatment, have prescription coverage, and meet financial eligibility criteria based on household income and size.

The Assistance Fund

The Myasthenia Gravis Financial Assistance Program by The Assistance Fund offers financial aid for out-of-pocket costs including prescription drugs, health insurance premiums, therapy administration, and travel expenses such as ground transportation, air travel, meals, and hotel stays to treatment centers or physicians. To qualify, patients must be U.S. citizens or permanent residents diagnosed with Myasthenia Gravis, prescribed an FDA-approved treatment, have prescription coverage, and meet financial eligibility criteria based on household income and size.

Bristol Myers Squibb (BMS)

The MyCAMZYOS Co-Pay Program helps commercially insured patients reduce out-of-pocket costs for their CAMZYOS prescription, potentially to as little as $10 per 30-day supply. It also includes a Bridge Program for delayed insurance coverage and a Free 35-Day Trial Offer. Eligibility requires patients to be 18 or older, reside in the U.S. or its territories, have commercial insurance, and not be enrolled in state or federal healthcare programs.

Bristol Myers Squibb

MyCAMZYOS Patient Support offers financial assistance for CAMZYOS medication, including a Co-Pay Program for commercially insured patients, a Bridge Program for coverage delays, and a 35-day Free Trial Offer. Eligibility is for patients with commercial insurance, excluding those with state/federal healthcare programs or cash-paying status. This program does not offer travel assistance.

PAN Foundation

This grant, offered by the PAN Foundation, provides assistance primarily for medication copays for patients with Myelodysplastic syndrome. Although the foundation also offers transportation grants and generally states that grants can cover transportation purchases, specific details for this fund's travel assistance are not explicitly outlined. Eligibility typically requires patients to meet certain income and insurance premium criteria.

Spark Therapeutics

Spark Therapeutics Generation Patient Services offers support to patients with confirmed biallelic RPE65 gene mutation-associated retinal dystrophy. The program provides a support team, assists with navigating insurance coverage, connects patients with financial assistance resources, and helps coordinate visits to treatment centers. Enrollment is voluntary for eligible patients.

National Assistance Foundation

The National CML Society's Assistance Programs help CML patients and their family members navigate and apply for various patient assistance programs. This includes assistance with drug-specific co-pay programs and referrals to other organizations that provide lodging, flights, and local transportation assistance.

National Assistance Foundation

This page from the National Kidney Foundation focuses on resources for prescription discounts and assistance, rather than direct financial grants for patient travel. Information regarding travel assistance, such as coverage for flights, hotel, or gas, is not provided on this resource page.

PAN Foundation

The PAN Foundation offers the Neurofibromatosis medications copay assistance grant for eligible patients to help with medication costs. The foundation also provides general transportation grants which may cover transportation purchases; however, specific details about the types of travel expenses covered by this fund (e.g., flights, hotel, gas) or any minimum travel distance requirements are not specified on this page.

The Assistance Fund

This program, sponsored by The Assistance Fund, provides financial assistance for patients diagnosed with Neuromyelitis Optica Spectrum Disorder. It covers out-of-pocket costs such as prescription drugs, health insurance premiums, therapy administration, and travel expenses including ground transportation, flights, hotel stays, and meals to treatment centers or physician appointments. Eligible patients must be U.S. citizens/permanent residents, have an FDA-approved treatment with prescription coverage, and meet financial eligibility criteria.

PAN Foundation

Bayer

The Nexavar REACH assistance program helps patients prescribed Nexavar access their medication by identifying specialty pharmacies and addressing insurance and reimbursement concerns. While the Nexavar website focuses on FDA-approved conditions, Bayer also assists GIST patients prescribed Nexavar off-label. Patients can contact a REACH Program Counselor or have their physician help complete the application.

Pfizer

The Nivestym Co-pay Assistance program, offered by Pfizer Oncology Together, helps commercially insured patients cover out-of-pocket expenses, including co-pays or coinsurance, for NIVESTYM® treatment. Eligible patients may pay as little as $0 per treatment, with a maximum benefit of $10,000 per calendar year, and there are no income requirements to qualify. This program is not available to patients enrolled in state- or federally funded prescription insurance programs.

PAN Foundation

This grant, offered by the PAN Foundation, provides financial assistance for medication copays to patients diagnosed with Non-Hodgkin's lymphoma. Applicants are required to verify their income to determine eligibility for the fund, which appears to be open for applications.